Global pharma major Lupin Limited on Thursday announced that it has received tentative approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug ...
Lupin shares continue to rise, trading at a new 52-week high of Rs 2,376 after a 15% return over two weeks. The Nifty Pharma index's December outperformance highlights buying interest in pharma stocks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback